Preeminent Clinical Endocrinology Association Celebrates Passage of Legislation to Enhance Diabetes Care

Thursday, October 12, 2017 7:54 am EDT

Dateline:

Washington, D.C.
"We would like to extend our appreciation to the bill sponsors, Representative Pete Olson and Representative Dave Loebsack in the House, Senator Susan Collins and Senator Jeanne Shaheen in the Senate, and the many other legislators and organizations that joined us in support of this critical legislation."

WASHINGTON, D.C. – (October 11, 2017) – The American Association of Clinical Endocrinologists (AACE) is pleased to announce final passage of the National Clinical Care Commission Act (S.920) today by the U.S. House of Representatives.  The House previously passed its version of the bill (H.R. 309) earlier this year.

The legislation, championed by AACE with the support of the entire diabetes community, establishes a public/private commission of expert researchers, clinical endocrinology physicians, specialists, primary care physicians, allied healthcare professionals and patient advocacy representatives. The commission will collectively assess existing federal programs that support clinical care for individuals with complex diabetes, metabolic or autoimmune disease or complications caused by such diseases. The commission is charged with the identification of inefficiencies and gaps in activities in federal government diabetes programs and providing recommendations to HHS and Congress to improve diabetes care in the U.S.

 Since the bill was first introduced in the U.S. House of Representatives in September 2011, the prevalence of diabetes has continued to surge: According to recent data, diabetes afflicts 9.4 percent of the U.S. population, with an additional 84.1 million Americans aged 18 years or older diagnosed as pre-diabetic. The total annual cost of diabetes in the U.S. is estimated at $245 billion.

 “As the lead organization advocating this legislation for the past six years, I am extraordinarily pleased personally and for our entire coalition that worked so hard to give our patients with diabetes an opportunity for a better life,” said AACE President Dr. Jonathan Leffert, FACP, FACE, ECNU. “We would like to extend our appreciation to the bill sponsors, Representative Pete Olson and Representative Dave Loebsack in the House, Senator Susan Collins and Senator Jeanne Shaheen in the Senate, and the many other legislators and organizations that joined us in support of this critical legislation.”

“Diabetes is a national epidemic that impacts a large number of Americans,” Rep. Pete Olson said. “Cutting-edge medical research and clinical care institutions only matter if we can translate that research into direct patient care. My bill will help ensure that Americans at risk of diabetes receive appropriate and effective preventive care and those with diabetes receive the same high-quality care and enjoy a better quality of life by successfully managing their disease. I want to thank House and Senate leadership for moving this bill and my colleagues for helping the millions of people with diabetes in America who will be helped by this legislation.”

To read the bill in its entirety, or to learn more about the National Clinical Care Commission Act, visit: https://www.congress.gov/bill/115th-congress/senate-bill/920?q=%7B%22search%22%3A%5B%22S.+920%22%5D%7D&r=1

###

About the American Association of Clinical Endocrinologists (AACE) 

The American Association of Clinical Endocrinologists (AACE) represents more than 7,000 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in Diabetes, Endocrinology and Metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. Visit our site at www.aace.com.